Published by Michele Maatouk on 28th May 2026
(Sharecast News) - GSK said on Thursday that late-stage trial results for its experimental drug for chronic hepatitis B, bepirovirsen, showed that it helped nearly one in five patients to achieve a functional cure.
URL: http://www.digitallook.com/dl/news/story/35962828/...